Panel & Networking Breakfast : How Can Emerging Biotechs De-Risk and Scale Through Smarter Partnerships?
This panel explores how emerging biotechs can de-risk development and accelerate value creation through smarter partnering strategies. It highlights how specialized partners can deliver targeted expertise across key stages—from discovery to commercialization—enabling faster decisions, more efficient capital use, and stronger investor-ready data. The discussion will also showcase Québec’s deep expertise across the biotech value chain.
Moderator: Maxime Pesant, VP Private Equity and Impact Investing | Life Sciences @ Fonds de solidarité FTQ
Panelists:
David Leroux-Petersen, CEO @ Corealis Pharma
Patrick Daoust, Business Development Specialist @ Biologics Manufacturing Centre (BMC) Inc.
Suzie Talbot, President & Founder @ Diex Research
Offered as a breakfast session, this event also provides a valuable opportunity for networking among participants.